Is CRXT or DIVO a better dividend investment in 2026?

CRXT currently yields 4210.53% with a 5% 5-year dividend growth rate. DIVO yields 4.00% with 5% growth. The better choice depends on your goal: CRXT offers higher current income.

What is the dividend yield difference between CRXT and DIVO?

CRXT has a forward dividend yield of 4210.53% ($2.00/share annually). DIVO yields 4.00% ($2.00/share annually). The yield gap is 4206.53 percentage points.

Home › Compare › CRXT vs DIVO

CRXT vs DIVO: Dividend Comparison 2026

CRXT yields 4210.53% · DIVO yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRXT wins by $11772529661935.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRXT

● Live price

4210.53%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11772529661935.08M

Annual income

$11,247,068,373,781,045,000.00

Full CRXT calculator →

DIVO

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full DIVO calculator →

Portfolio growth — CRXT vs DIVO

📍 CRXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRXT	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRXT + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRXT pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRXT

Annual income on $10K today (after 15% tax)

$357,894.74/yr

After 10yr DRIP, annual income (after tax)

$9,560,008,117,713,887,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, CRXT beats the other by $9,560,008,117,713,887,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRXT + DIVO for your $10,000?

CRXT: 50%DIVO: 50%

100% DIVO50/50100% CRXT

Portfolio after 10yr

$5886264830967.55M

Annual income

$5,623,534,186,890,523,000.00/yr

Blended yield

95.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CRXT right now

CRXT

Analyst Ratings

Buy

Hold

Consensus: Buy

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRXT buys

DIVO buys

No recent congressional trades found for CRXT or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRXTDIVO

Forward yield	4210.53% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$11772529661935.08M ✓	$28.0K
Annual income after 10y	$11,247,068,373,781,045,000.00 ✓	$899.19
Total dividends collected	$11736758602549.12M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CRXT vs DIVO ($10,000, DRIP)

Year	CRXT Portfolio	CRXT Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$431,753	$421,052.63	$11,120	$420.00	+$420.6K → CRXT
2	$17,451,749	$16,989,773.99	$12,357	$458.31	+$17.44M → CRXT
3	$660,485,318	$641,811,946.18	$13,721	$499.76	+$660.47M → CRXT
4	$23,407,888,248	$22,701,168,957.98	$15,227	$544.58	+$23407.87M → CRXT
5	$776,952,371,738	$751,905,931,312.87	$16,885	$593.02	+$776952.35M → CRXT
6	$24,155,814,960,562	$23,324,475,922,802.33	$18,713	$645.34	+$24155814.94M → CRXT
7	$703,574,699,225,543	$677,727,977,217,741.50	$20,724	$701.81	+$703574699.20M → CRXT
8	$19,201,286,500,349,684	$18,448,461,572,178,350.00	$22,938	$762.73	+$19201286500.33M → CRXT
9	$491,085,316,031,806,900	$470,539,939,476,432,700.00	$25,372	$828.41	+$491085316031.78M → CRXT
10	$11,772,529,661,935,080,000	$11,247,068,373,781,045,000.00	$28,047	$899.19	+$11772529661935.05M → CRXT

CRXT vs DIVO: Complete Analysis 2026

CRXT — Stock

Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

Full CRXT Calculator →

DIVO — ETF

DIVO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DIVO shares.

Full DIVO Calculator →

📬

Get this CRXT vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRXT vs SCHD CRXT vs JEPI CRXT vs O CRXT vs KO CRXT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.